Skip to main content

Want a detailed portfolio tracker?

Ensysce Biosciences (ENSC) P/E (2023 - 2026)

Ensysce Biosciences (ENSC) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM Ensysce Biosciences (ENSC) P/E is -0.10. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ensysce Biosciences (ENSC)

YearP/EChange
2026-0.10-60.23%
2025-0.25-80.88%
2024-1.31-64.29%
2023-3.66N/A

Comparison Ensysce Biosciences (ENSC) P/E with competitors

Ensysce Biosciences (ENSC) P/E is -0.10.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.71%
NBYStablecoin Development Corp0.00-104.33%
FGENFibroGen Inc0.24-341.84%
CHRSCoherus Biosciences Inc0.85-954.90%
FBIOFortress Biotech Inc0.95-1056.16%
ORMPOramed Pharmaceuticals Inc1.50-1614.34%
AGENAgenus Inc3.01-3132.21%
INVAInnoviva Inc3.15-3277.70%
VXRTVaxart Inc3.55-3676.38%
CRMDCorMedix Inc3.63-3755.68%
CVACCureVac N.V.4.45-4579.04%
GLPGGalapagos NV4.86-4995.36%
SRPTSarepta Therapeutics Inc4.88-5018.74%
ABEOAbeona Therapeutics Inc5.39-5527.95%
ABUSArbutus Biopharma Corp5.60-5737.62%
ZVRAZevra Therapeutics Inc5.89-6031.42%
SPROSpero Therapeutics Inc6.23-6375.20%
CGENCompugen Ltd6.31-6461.34%
RIGLRigel Pharmaceuticals6.87-7023.65%
SLXNSilexion Therapeutics Corp7.30-7450.85%
OMEROmeros Corporation9.26-9428.26%
AUPHAurinia Pharmaceuticals Inc9.58-9756.92%
PLXProtalix BioTherapeutics Inc10.89-11072.78%
ACADAcadia Pharmaceuticals Inc11.73-11916.60%
TBPHTheravance Biopharma Inc12.26-12454.22%
ADMAAdma Biologics Inc12.42-12611.40%
HRMYHarmony Biosciences Holdings Inc13.82-14023.98%
SABSSAB Biotherapeutics Inc14.14-14342.36%
NAGENiagen Bioscience Inc14.82-15029.41%
INCYIncyte Corp15.82-16041.39%
REGNRegeneron Pharmaceuticals Inc15.86-16075.74%
PBYIPuma Biotechnology Inc17.32-17545.75%
CPRXCatalyst Pharmaceuticals Inc17.44-17670.28%
EXELExelixis Inc17.54-17769.73%
TGTXTG Therapeutics Inc18.97-19208.50%
MDXGMimedx Group Inc20.55-20806.87%
XOMAXOMA Royalty Corp22.87-23147.10%
ARGXArgen X SE24.30-24581.14%
CTMXCytomX Therapeutics Inc24.82-25108.19%
XOMAOXOMA Royalty Corp25.34-25635.84%
HALOHalozyme Therapeutics Inc25.62-25916.84%
XOMAPXOMA Royalty Corp25.67-25963.59%
VRTXVertex Pharmaceuticals Inc27.99-28305.73%
RPRXRoyalty Pharma plc - Class A28.69-29003.76%
SLNOSoleno Therapeutics Inc29.02-29334.04%
ASNDAscendis Pharma A/S30.09-30412.31%
LGNDLigand Pharmaceuticals Inc - Class B37.91-38297.76%
APLSApellis Pharmaceuticals Inc39.02-39415.33%
BMRNBiomarin Pharmaceutical Inc42.21-42630.01%
KRYSKrystal Biotech Inc45.34-45785.24%
ONCBeiGene Ltd69.54-70164.62%
PHARPharming Group N.V.75.03-75691.11%
TECHBio-Techne Corp101.96-102826.93%
VCELVericel Corp109.92-110849.91%
ALNYAlnylam Pharmaceuticals Inc117.96-118954.31%
GMABGenmab140.29-141448.26%
TLXTelix Pharmaceuticals Ltd162.15-163475.12%
CORTCorcept Therapeutics Inc212.86-214562.02%